LOS ANGELES, CA / ACCESSWIRE / December 1, 2016 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN) concerning possible violations of federal securities laws between February 10, 2014 and November 9, 2016 inclusive (the "Class Period"). Investors who purchased or otherwise acquired shares during the Class Period are encouraged to contact the firm in advance of the January 17, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, Alexion made false and/or misleading statements and/or failed to disclose: that Alexion employed improper sales practices with respect to its product Soliris; that the Company's revenues from Soliris sales were unlikely to be sustainable; and that as a result of the above, Alexion's public statements were materially false and misleading at all relevant times. On November 4, 2016, Alexion cancelled an appearance at the Credit Suisse Healthcare Conference. Following the cancellation, analysts noticed that the Company also failed to file its Quarterly Report on Form 10-Q with the SEC within two days of its earnings announcement on October 27, 2016. On November 9, 2016, Alexion announced that the Company would not be able to timely file its financial and operating results for the quarter ended September 30, 2016. When this news was released to the public, the value of Alexion fell, causing investors severe harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC